Literature DB >> 17220890

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Ekaterina Rogaeva1, Yan Meng, Joseph H Lee, Yongjun Gu, Toshitaka Kawarai, Fanggeng Zou, Taiichi Katayama, Clinton T Baldwin, Rong Cheng, Hiroshi Hasegawa, Fusheng Chen, Nobuto Shibata, Kathryn L Lunetta, Raphaelle Pardossi-Piquard, Christopher Bohm, Yosuke Wakutani, L Adrienne Cupples, Karen T Cuenco, Robert C Green, Lorenzo Pinessi, Innocenzo Rainero, Sandro Sorbi, Amalia Bruni, Ranjan Duara, Robert P Friedland, Rivka Inzelberg, Wolfgang Hampe, Hideaki Bujo, You-Qiang Song, Olav M Andersen, Thomas E Willnow, Neill Graff-Radford, Ronald C Petersen, Dennis Dickson, Sandy D Der, Paul E Fraser, Gerold Schmitt-Ulms, Steven Younkin, Richard Mayeux, Lindsay A Farrer, Peter St George-Hyslop.   

Abstract

The recycling of the amyloid precursor protein (APP) from the cell surface via the endocytic pathways plays a key role in the generation of amyloid beta peptide (Abeta) in Alzheimer disease. We report here that inherited variants in the SORL1 neuronal sorting receptor are associated with late-onset Alzheimer disease. These variants, which occur in at least two different clusters of intronic sequences within the SORL1 gene (also known as LR11 or SORLA) may regulate tissue-specific expression of SORL1. We also show that SORL1 directs trafficking of APP into recycling pathways and that when SORL1 is underexpressed, APP is sorted into Abeta-generating compartments. These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220890      PMCID: PMC2657343          DOI: 10.1038/ng1943

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  47 in total

1.  A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information.

Authors:  D Rabinowitz; N Laird
Journal:  Hum Hered       Date:  2000 Jul-Aug       Impact factor: 0.444

2.  Risk of dementia among white and African American relatives of patients with Alzheimer disease.

Authors:  Robert C Green; L Adrienne Cupples; Rodney Go; Kelly S Benke; Timi Edeki; Patrick A Griffith; Mary Williams; Yvonne Hipps; Neill Graff-Radford; David Bachman; Lindsay A Farrer
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

3.  Score tests for association between traits and haplotypes when linkage phase is ambiguous.

Authors:  Daniel J Schaid; Charles M Rowland; David E Tines; Robert M Jacobson; Gregory A Poland
Journal:  Am J Hum Genet       Date:  2001-12-27       Impact factor: 11.025

4.  Are rare variants responsible for susceptibility to complex diseases?

Authors:  J K Pritchard
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

5.  Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing.

Authors:  G Yu; M Nishimura; S Arawaka; D Levitan; L Zhang; A Tandon; Y Q Song; E Rogaeva; F Chen; T Kawarai; A Supala; L Levesque; H Yu; D S Yang; E Holmes; P Milman; Y Liang; D M Zhang; D H Xu; C Sato; E Rogaev; M Smith; C Janus; Y Zhang; R Aebersold; L S Farrer; S Sorbi; A Bruni; P Fraser; P St George-Hyslop
Journal:  Nature       Date:  2000-09-07       Impact factor: 49.962

6.  Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.

Authors:  S Benjannet; A Elagoz; L Wickham; M Mamarbachi; J S Munzer; A Basak; C Lazure; J A Cromlish; S Sisodia; F Checler; M Chrétien; N G Seidah
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

7.  A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.

Authors:  E S Athan; J Williamson; A Ciappa; V Santana; S N Romas; J H Lee; H Rondon; R A Lantigua; M Medrano; M Torres; S Arawaka; E Rogaeva; Y Q Song; C Sato; T Kawarai; K C Fafel; M A Boss; W K Seltzer; Y Stern; P St George-Hyslop; B Tycko; R Mayeux
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

8.  Nicastrin binds to membrane-tethered Notch.

Authors:  F Chen; G Yu; S Arawaka; M Nishimura; T Kawarai; H Yu; A Tandon; A Supala; Y Q Song; E Rogaeva; P Milman; C Sato; C Yu; C Janus; J Lee; L Song; L Zhang; P E Fraser; P H St George-Hyslop
Journal:  Nat Cell Biol       Date:  2001-08       Impact factor: 28.824

Review 9.  Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport.

Authors:  T A Bayer; O Wirths; K Majtényi; T Hartmann; G Multhaup; K Beyreuther; C Czech
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

10.  Prevalence of Alzheimer's type dementia in an elderly Arab population.

Authors:  A Bowirrat; T A Treves; R P Friedland; A D Korczyn
Journal:  Eur J Neurol       Date:  2001-03       Impact factor: 6.089

View more
  478 in total

1.  Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.

Authors:  Lei Yu; Lori B Chibnik; Gyan P Srivastava; Nathalie Pochet; Jingyun Yang; Jishu Xu; James Kozubek; Nikolaus Obholzer; Sue E Leurgans; Julie A Schneider; Alexander Meissner; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

2.  Exploring the epigenetics of Alzheimer disease.

Authors:  Bryan J Traynor; Alan E Renton
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

Review 3.  Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.

Authors:  Richard Mayeux; Nicole Schupf
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

4.  Retromer disruption promotes amyloidogenic APP processing.

Authors:  Christopher P Sullivan; Anthony G Jay; Edward C Stack; Maria Pakaluk; Erin Wadlinger; Richard E Fine; John M Wells; Peter J Morin
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

Review 5.  Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology.

Authors:  Daniel J Glass; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2011-12-03       Impact factor: 21.566

6.  A comprehensive genetic association study of Alzheimer disease in African Americans.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; Jacki Buros; Robert C Green; Rodney C P Go; Patrick Griffith; Thomas O Obisesan; Rhonna Shatz; Amy Borenstein; L Adrienne Cupples; Kathryn L Lunetta; M Daniele Fallin; Clinton T Baldwin; Lindsay A Farrer
Journal:  Arch Neurol       Date:  2011-12

7.  SorLA in glia: shared subcellular distribution patterns with caveolin-1.

Authors:  Iris K Salgado; Melissa Serrano; José O García; Namyr A Martínez; Héctor M Maldonado; Carlos A Báez-Pagán; José A Lasalde-Dominicci; Walter I Silva
Journal:  Cell Mol Neurobiol       Date:  2011-11-30       Impact factor: 5.046

Review 8.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 9.  Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress.

Authors:  Sam Gandy; Steven T DeKosky
Journal:  Annu Rev Med       Date:  2013       Impact factor: 13.739

10.  Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; John Farrell; Kathryn L Lunetta; Gyungah Jun; Clinton T Baldwin; Margaret M Deangelis; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.